Carbamic acid derivatives as selective immunosuppresive agents
US4450159A · kind A · utility
5Cited by
8References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 8, 1979 |
| Grant date | May 22, 1984 |
| Priority date | — |
| Expiry date | Aug 8, 1999 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D279/06
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Novel cyclized .omega.-carboxyethyl mono or dithiocarbanilic acids are disclosed as immunoregulatory agents, useful in the treatment of organ transplant reject phenomenon and autoimmune diseases particularly where a delayed hypersensitivity component has been established, such as multiple sclerosis. Additionally described is the use of certain cyclized .omega.-carboxyalkyl mono- or dithiocarbamic acids and certain cyclized .omega.-carboxyalkyl mono- or dithiocarbamic acids.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.